DISABLED ENTREPRENEUR – DISABILITY UK
Disability UK Online Health Journal – All In One Business In A Box – Forum – Business Directory – Useful Resources – Health – Human Rights – Politics
DISABLED ENTREPRENEUR – DISABILITY UK
Disability UK Online Health Journal – All In One Business In A Box – Forum – Business Directory – Useful Resources – Health – Human Rights – Politics
Browsing Category
Multiple sclerosis research has produced an intriguing new development following the publication of a study involving an experimental medicine called kamuvudine-9, also known as K-9. Researchers have reported that K-9 was able not only to prevent further neurological deterioration in a laboratory model of multiple sclerosis but also to reverse existing paralysis and vision loss in mice.
UK clinical trial reforms took effect in April 2026. Learn what they mean for experimental treatments, EAMS, patient safety and disabled people.
As the MHRA tightens its oversight of Kenalog advertising, it sends a clear message that the promotion of medications must prioritize patient safety above all else. By fostering transparency and accountability in pharmaceutical marketing, regulatory authorities can help safeguard the well-being of individuals who rely on these medications for their health needs.